What is Actos?

Actos is a prescription medication used in the treatment of type 2 diabetes. The drug is sold under the generic name pioglitazone. Actos is manufactured and sold by Takeda Pharmaceuticals North America, Inc., which is a part of the Japanese company Takeda Limited.

Actos was approved by the Food and Drug Administration (FDA) in 1999 and has since become one of the most frequently prescribed medications for patients with type 2 diabetes. In 2010 alone, more than two million prescriptions were written for the medication.

Actos Linked to Bladder Cancer

Recent medical research has shown a link to Actos and an increased risk of bladder cancer. After one study published findings that taking Actos over the long-term can increase a person’s risk of bladder cancer by nearly 40 percent, Germany and France declared that they would ban sales of Actos in June of 2011. Also during that same period, the FDA announced its own alert regarding the risk of bladder cancer associated with prolonged use of Actos.

Health Canada released a warning in April of 2012 after further research showed that the risk of bladder cancer from taking Actos may be higher than 40 percent. In May of 2012, the British Medical Journal published the findings from research that was conducted at McGill University in Montreal. Their findings showed that continued use of Actos could increase a person’s risk of bladder cancer by as much as 83 percent.

Actos Lawsuits

According to Bloomberg News, Takeda Pharmaceuticals could face nearly 10,000 Actos lawsuits from patients who have taken Actos and developed bladder cancer. Due to the large number of people who are pursuing legal action, all lawsuits are being handled by a multi-district federal court located in Louisiana. The case is called In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).

The litigation proceedings are being managed by Judge Rebecca Doherty, who has scheduled the trials for the Actos lawsuit to begin in November 2014.

Choosing an Actos Lawyer to Represent You

All patients who have suffered from bladder cancer as a result of taking Actos are strongly encouraged to discuss their legal options with an Actos attorney as soon as possible. It is possible to receive significant compensation. There may be a limited amount of time in which a case can be filed.

Since federal drug injury cases are highly specialized in nature, it is crucial to choose an Actos injury attorney who has experience in working multi-district litigation. Speak with a law firm to learn more about research linking Actos to bladder cancer, side effects from the medication or news related to litigation.